Use of Angiotensin Receptor Blockers In Cardiovascular Protection - PMC Back to Top Skip to
main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content …

Background Accurate quantification of left ventricular mass and ejection fraction is important
for patients with left ventricular hypertrophy. Although cardiac magnetic resonance imaging …

Cardiovascular toxicity in the form of cardiac dysfunction continues to be an obstacle for
patients with cancer. Survival and quality of life of cancer survivors are frequently affected by …

Aims Global measures of left ventricular (LV) function, in particular LV ejection fraction
(LVEF) and global myocardial strain measures, are powerful predictors of outcomes in …

Background Identifying risk factors for specific modes of death in patients with heart failure
(HF) or left ventricular (LV) dysfunction after acute myocardial infarction (MI) may help to …

Background Left ventricular (LV) dysfunction may be sustained or aggravated during the
convalescent months following an acute myocardial infarction (MI) and is difficult to predict …

Objectives: The purpose of this study was to determine whether alterations in cardiac
structure or function contribute to the increased risk associated with renal impairment after …

Erythropoietin (EPO), a glycoprotein essential for red blood cell production acts on several
non-erythropoietic tissues. The EPO receptor (EPOR) is expressed in a variety of cell types …

Our previous study demonstrated that periostin, an extracellular matrix protein, plays an
important role in left ventricular remodeling through the inhibition of cell–cell interactions …

Background The evolution and clinical impact of cardiac remodeling after large ST-elevation
myocardial infarction (STEMI) is not well delineated in the current therapeutic era. Methods …